BI dives deeper into cancer immunotherapy with new acquisition – Danbury News Times
Danbury News TimesBI dives deeper into cancer immunotherapy with new acquisitionDanbury News TimesThe pharmaceutical giant, which has its North American headquarters in Ridgefield, announced a collaboration and license agreement with OSE Immunotherapeu… Continue reading
